Next-generation imaging promises sharper, deeper view of living tissues A University of Arizona research team will receive nearly $2.7 million from the NIH's Common Fund Venture Program to advance next-generation imaging technologies that allow deeper, clearer views inside the body without the need for invasive procedures.
https://www.news-medical.net/n....ews/20251007/Next-ge

Study reveals early nicotinamide use reduces risk of aggressive skin cancers A large U.S. Department of Veterans Affairs cohort study found that Nicotinamide use was associated with a 14% lower risk of new keratinocyte skin cancers, driven by a 22% reduction in cSCC and no reduction in BCC. The strongest benefit (56% lower risk) appeared when nicotinamide was started after a patient’s first skin cancer, with diminishing returns after multiple cancers.
https://www.news-medical.net/n....ews/20250918/Study-r

Study reveals early nicotinamide use reduces risk of aggressive skin cancers A large U.S. Department of Veterans Affairs cohort study found that Nicotinamide use was associated with a 14% lower risk of new keratinocyte skin cancers, driven by a 22% reduction in cSCC and no reduction in BCC. The strongest benefit (56% lower risk) appeared when nicotinamide was started after a patient’s first skin cancer, with diminishing returns after multiple cancers.
https://www.news-medical.net/n....ews/20250918/Study-r

New molecule offers a more targeted and potent immunotherapy A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein can both block the "do not attack" signal used by cancer cells and selectively activate tumor-fighting immune cells. This dual action could pave the way for more effective cancer therapies with fewer side effects.
https://www.news-medical.net/n....ews/20250918/New-mol

Simple AI model matches dermatologist expertise in assessing squamous cell carcinoma A simple AI model has been shown to perform on a par with experienced dermatologists when assessing the aggressiveness of a common form of skin cancer, squamous cell carcinoma. The research was headed by the University of Gothenburg.
https://www.news-medical.net/n....ews/20250913/Simple-